205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-10.04%
Revenue decline while AVGO shows 4.72% growth. Joel Greenblatt would examine competitive position erosion.
-4.14%
Cost reduction while AVGO shows 6.49% growth. Joel Greenblatt would examine competitive advantage.
-13.64%
Gross profit decline while AVGO shows 3.94% growth. Joel Greenblatt would examine competitive position.
-4.00%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-2.34%
R&D reduction while AVGO shows 2.21% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.71%
Operating expenses reduction while AVGO shows 2.77% growth. Joel Greenblatt would examine advantage.
-3.64%
Total costs reduction while AVGO shows 4.87% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
5.31%
D&A change of 5.31% while AVGO maintains D&A. Bruce Berkowitz would investigate efficiency.
-15.26%
EBITDA decline while AVGO shows 7.98% growth. Joel Greenblatt would examine position.
-5.80%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-18.97%
Operating income decline while AVGO shows 9.96% growth. Joel Greenblatt would examine position.
-9.93%
Operating margin decline while AVGO shows 5.00% growth. Joel Greenblatt would examine position.
-50.00%
Other expenses reduction while AVGO shows 3.19% growth. Joel Greenblatt would examine advantage.
-19.46%
Pre-tax income decline while AVGO shows 11.00% growth. Joel Greenblatt would examine position.
-10.47%
Pre-tax margin decline while AVGO shows 5.99% growth. Joel Greenblatt would examine position.
-16.90%
Tax expense reduction while AVGO shows 63.47% growth. Joel Greenblatt would examine advantage.
-19.78%
Net income decline while AVGO shows 6.69% growth. Joel Greenblatt would examine position.
-10.82%
Net margin decline while AVGO shows 1.88% growth. Joel Greenblatt would examine position.
-20.21%
EPS decline while AVGO shows 6.25% growth. Joel Greenblatt would examine position.
-19.46%
Diluted EPS decline while AVGO shows 7.79% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Diluted share reduction while AVGO shows 0.00% change. Joel Greenblatt would examine strategy.